Adi Natu
Background and experience
As a principal in ZS’s value and access practice, Adi partners with global biopharma clients to shape pricing strategies and strengthen market access for innovative therapies.
Adi’s deep experience and thought leadership in the global market access and pricing space has been shaped over the past 14 years through strategic engagement with clients around the world, including North America, EU5, Japan, Latin America, Eastern Europe and Africa. His passion is in the intersection of science and business, helping clients define market access and pricing strategies for pipeline and inline assets. Adi’s experience spans a variety of therapy areas, including oncology, vaccines, immunology and infectious diseases.
Before joining ZS in 2008, Adi worked as a strategy consultant with Oliver Wyman, where he focused on strategy and operations projects across various industries.
Education
MBA, concentration in strategy and finance, Duke University’s Fuqua School of Business
Bachelor of Science, chemical engineering, University of Mumbai
Master of Science, petroleum engineering, University of Tulsa